Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al

Detalles Bibliográficos
Autores principales: Mora, Jaume, Chantada, Guillermo L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666882/
https://www.ncbi.nlm.nih.gov/pubmed/34893525
http://dx.doi.org/10.1136/jitc-2021-003751
_version_ 1784614287619129344
author Mora, Jaume
Chantada, Guillermo L
author_facet Mora, Jaume
Chantada, Guillermo L
author_sort Mora, Jaume
collection PubMed
description
format Online
Article
Text
id pubmed-8666882
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86668822021-12-28 Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al Mora, Jaume Chantada, Guillermo L J Immunother Cancer Letter BMJ Publishing Group 2021-12-10 /pmc/articles/PMC8666882/ /pubmed/34893525 http://dx.doi.org/10.1136/jitc-2021-003751 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Mora, Jaume
Chantada, Guillermo L
Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al
title Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al
title_full Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al
title_fullStr Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al
title_full_unstemmed Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al
title_short Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al
title_sort correspondence on "g-csf as a suitable alternative to gm-csf to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by martinez sanz et al
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666882/
https://www.ncbi.nlm.nih.gov/pubmed/34893525
http://dx.doi.org/10.1136/jitc-2021-003751
work_keys_str_mv AT morajaume correspondenceongcsfasasuitablealternativetogmcsftoboostdinutuximabmediatedneutrophilcytotoxicityinneuroblastomatreatmentbymartinezsanzetal
AT chantadaguillermol correspondenceongcsfasasuitablealternativetogmcsftoboostdinutuximabmediatedneutrophilcytotoxicityinneuroblastomatreatmentbymartinezsanzetal

Ejemplares similares